More Bad News For Genzyme: This Time, A Phase II/III Phosphate Binder Disappoints
This article was originally published in The Pink Sheet Daily
Executive Summary
Genzyme is scrapping development of a Renvela/Renagel follow-on after it failed to show a significant advantage.